On November 23, 2020 ViewRay, Inc. (NASDAQ: VRAY) reported its participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference (Press release, ViewRay, NOV 23, 2020, View Source [SID1234571615]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

From November 23 to December 3, 2020, a fireside chat recording will be available for registered attendees via the Piper Sandler conference site. A recording will also be posted to the Company’s website at View Source

ViewRay will be participating in investor meetings on Tuesday, December 1st, which can be requested exclusively via Piper Sandler.

On November 23, 2020  Crinetics Pharmaceuticals (Nasdaq: CRNX), reported that company management will participate in the following conferences in the month of December. Please see additional details below (Press release, Crinetics Pharmaceuticals, NOV 23, 2020, View Source [SID1234571556]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

EVERCORE ISI 3RD ANNUAL HEALTHCONX CONFERENCE
Date: Thursday, December 3rd, 2020
Time: 1:00-1:45 pm ET in Track 1
Panel: Easy Pills to Swallow: Oral Drugs for Large Endo Markets
Presenter: Dr. Scott Struthers, Founder & CEO

PIPER SANDLER’S 32ND ANNUAL HEALTHCARE CONFERENCE
Date: Tuesday – Thursday, December 1st-3rd, 2020
Time: On demand
Presenter: Dr. Scott Struthers, Founder & CEO, and Dr. Alan Krasner, Chief Medical Officer

Webcast: Pre-recorded fireside chats will be available for viewing until the 3rd here 32nd annual Piper Sandler Healthcare Conference and the Piper Sandler conference website.

On November 23, 2020 Boston Scientific Corporation (NYSE: BSX) reported to participate in the 2020 Evercore ISI HealthCONx Conference on December 1 (Press release, Boston Scientific, NOV 23, 2020, View Source [SID1234571575]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mike Mahoney, chairman and chief executive officer, and Susie Lisa, vice president, Investor Relations will participate in a 45-minute question-and-answer session with the host analyst beginning at approximately 8:00 a.m. EST.

A live webcast and replay of the webcast will be accessible at investors.bostonscientific.comView Source The replay will be available beginning approximately one hour following the completion of each event.

On November 23, 2020 Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ("Eagle" or the "Company") reported that the Company’s pre-recorded presentation at the Piper Sandler 32nd Annual Virtual Healthcare Conference is now available for viewing via the link below (Press release, Eagle Pharmaceuticals, NOV 23, 2020, View Source [SID1234571592]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

View Source

It is also available on the Company’s website at www.eagleus.com, under the Investors section, where it will be archived for 30 days.

Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will be participating in 1×1 meetings on December 1, 2020. Meetings can be requested exclusively via Piper Sandler.

On November 23, 2020 Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, reported that Douglas E. Onsi, President and Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference, being held on December 1-3, 2020 (Press release, Leap Therapeutics, NOV 23, 2020, View Source [SID1234571617]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A pre-recording of the fireside chat is currently available on the Investors page of the company’s website at View Source A replay of the event will be available for 90 days.